Jay Shepard - 01 Jun 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Reporting relationship: Director
Issuer ticker: IRWD
Reported as of: 01 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2022, 16:06:36 UTC
Prior SEC filing: 27 May 2022
Next SEC filing: 17 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Brian Tessler, Attorney-in-Fact

Key filing fact

Jay Shepard filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 03 Jun 2022.

Key facts

This page summarizes Jay Shepard's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2022, 16:06.

Change

Previous filing in this sequence was filed on 27 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRWD transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +21,571
Change %: +37%
Price: $0.000000
Shares after: 79,894
Date: 01 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

SEC remarks

Exhibit 24: Power of Attorney